Gyre Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $8.7M | $39.5M | $14.5M |
| FY2018 | $5.0M | $124.9M | $31.2M |
| FY2019 | $30.2M | $98.6M | $15.4M |
| FY2020 | $18.8M | $94.8M | $30.4M |
| FY2021 | $14.6M | $55.7M | $44.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $8.7M | $39.5M | $14.5M |
| FY2018 | $5.0M | $124.9M | $31.2M |
| FY2019 | $30.2M | $98.6M | $15.4M |
| FY2020 | $18.8M | $94.8M | $30.4M |
| FY2021 | $14.6M | $55.7M | $44.3M |